AVGO vs CWAN Stock Comparison
CWAN currently leads AVGO in this stock comparison, with AIQ scores of 50 vs 49. The clearest difference is risk resilience, while AVGO has the stronger quality profile.
What is the main difference between AVGO and CWAN?
CWAN leads the current stock comparison as Clearwater Analytics Holdings, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Broadcom Inc. vs Clearwater Analytics Holdings, Inc.
CWAN leads
CWAN leads by 1 AIQ points, primarily on Risk Resilience and Value, having only recently taken the lead back from AVGO. Wall Street currently favors AVGO on target upside.
Fragile: 3 of 6 evidence groups support CWAN, and the lead recently changed hands.
Broadcom Inc.
Clearwater Analytics Holdings, Inc.
The Algovestiq AIQ Score currently favors CWAN over AVGO, 50 versus 49 as of Oct 21, 2026. CWAN's advantage is driven primarily by stronger risk resilience and value, while AVGO holds the stronger quality profile. CWAN also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors AVGO. 3 of 6 covered evidence groups favor CWAN today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. CWAN lead: Reversed — AVGO led by 3 AIQ points 30 sessions ago; CWAN now leads by 1.
Compare Broadcom Inc. and Clearwater Analytics Holdings, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare AVGO and CWAN against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality85 vs 53AVGO +32
- Risk Resilience53 vs 74CWAN +21
- Value30 vs 36CWAN +6
3 of 6 evidence groups favor CWAN. CWAN’s edge is concentrated in risk resilience and value; AVGO keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 3 active signals are unchanged.
No factor moved materially.
No signal started or stopped since the prior session.
CWAN's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — AVGO and CWAN both carry a full feed there.
The central trade-off
CWAN (Clearwater Analytics Holdings, Inc.): the stronger current systematic profile, led by risk resilience and value.
AVGO (Broadcom Inc.): the counter-case, on quality, fundamentals, analyst expectations — but at materially higher volatility, 36.5% against 4.4%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CWANCWAN on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
CWANCWAN on combined revenue and EPS growth.
Value
CWANCWAN on the peer-relative Value factor, by 6 points.
Momentum
EvenThe two are level on Momentum.
Lower downside
CWANCWAN on Risk Resilience, by 21 points.
Analyst upside
AVGOAVGO on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors CWAN, analyst targets favor AVGO. That disagreement is the most useful thing on this page.
| Measure | AVGO | CWAN | Note |
|---|---|---|---|
| Implied upside to target | +48.9% | 0% | AVGO has more room |
| Target dispersion | +49.7% | 0% | Lower is tighter analyst agreement |
| Consensus | Buy | Hold | Context, not a primary driver |
| Analysts covering | 18 | 1 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor CWAN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 49 vs 50 |
| Fundamentals | AVGOon balance | revenue growth 14.9% vs 1.7%; EPS growth 26.5% vs 76.5%; TTM ROE 36.4% vs -2.4%; gross margin 67% vs 66% — AVGO takes 3 of 4 decided legs, not all of them |
| Valuation | CWAN | Value 30 vs 36 |
| Technicals | CWAN | Price vs 50-day -6.7% vs 1.1%; vs 200-day -9.1% vs 10.2% |
| Risk Resilience | CWAN | Risk Resilience 53 vs 74 |
| Analyst expectations | AVGO | Target upside 48.9% vs 0% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of AVGO and CWAN and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CWAN.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20CWAN lead: Reversed — AVGO led by 3 AIQ points 30 sessions ago; CWAN now leads by 1.
- Today
- CWAN +1
- 49 vs 50
- 7 sessions ago
- AVGO +2
- 52 vs 50
- 30 sessions ago
- AVGO +3
- 53 vs 50
- 90 sessions ago
- AVGO +7
- 57 vs 50
The lead changed hands 4 times in this window, most recently on Oct 19 when CWAN moved ahead of AVGO.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
0 bullish / 3 bearish
Only AVGO
- Death Cross Active — bearish, trend, long horizon (1.65%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Bearish Crossover — bearish, momentum, short horizon
No active signals
No signal that the other name lacks.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.03%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1AVGO closes the Risk Resilience gap — currently 21 points behind, the largest single contributor to CWAN's edge.
- 2AVGO's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3CWAN starts generating bearish momentum or trend signals.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
AVGO leads on balance| Metric | AVGO | CWAN |
|---|---|---|
| Revenue growth (YoY) | 14.9% | 1.7% |
| EPS growth (YoY) | 26.5% | 76.5% |
| Gross margin | 67% | 66% |
| Operating margin | 43.7% | -0.7% |
| Return on equity (TTM) | 36.4% | -2.4% |
| Debt to equity | 0.74 | 0.42 |
Performance
CWAN leads 6 of 6 windows| Metric | AVGO | CWAN |
|---|---|---|
| 1 week (5 sessions) | -6.4% | 1.3% |
| 1 month (20 sessions) | -8.3% | 0.8% |
| 3 months (63 sessions) | -15.7% | 5.9% |
| 6 months (126 sessions) | -16.4% | 10.4% |
| Year to date | -3.4% | 1.8% |
| 1 year (252 sessions) | -5.6% | 15.5% |
Technicals
CWAN has the stronger structure| Metric | AVGO | CWAN |
|---|---|---|
| RSI (14) | 41.8 | 63.5 |
| ADX (14) | 21.4 | 25.8 |
| Price vs 50-day | -6.7% | 1.1% |
| Price vs 200-day | -9.1% | 10.2% |
| Volatility (1M, annualized) | 36.5% | 4.4% |
Risk
CWAN is the more resilient| Metric | AVGO | CWAN |
|---|---|---|
| Beta | 2.16 | 0.44 |
| Sharpe ratio | 0.05 | 1.1 |
| Sortino ratio | 0.07 | 1.42 |
| Max drawdown | -31.7% | -17.9% |
| Current drawdown | -30.6% | 0% |
| Annualized volatility | 45.9% | 28.3% |
| Value at risk (95%) | -4.4% | -1.9% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, AVGO or CWAN?
On the Algovestiq AIQ Score, CWAN is the stronger of the two as of Oct 21, 2026, scoring 50 against AVGO's 49. The edge comes from risk resilience and value. AVGO is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is AVGO or CWAN the better buy right now?
CWAN carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor CWAN over AVGO?
The composite weights Quality, Value, Momentum and Risk Resilience. AVGO leads Quality by 32 points; CWAN leads Risk Resilience by 21 points; CWAN leads Value by 6 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, AVGO or CWAN?
Analyst price targets imply +48.9% upside for AVGO and 0% for CWAN, so the Street currently favors AVGO. That points the opposite way to the AIQ Score, which favors CWAN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, AVGO or CWAN?
CWAN is the better-valued of the two on the peer-relative Value factor. CWAN on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, AVGO or CWAN?
CWAN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, AVGO or CWAN?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, AVGO or CWAN?
CWAN is the more resilient of the two, so the other name carries the higher downside risk. CWAN on Risk Resilience, by 21 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is AVGO more profitable than CWAN?
AVGO leads on the comparable margin measures — gross margin 67% vs 66%; operating margin 43.7% vs -0.7%; ttm roe 36.4% vs -2.4%.
Is CWAN's lead over AVGO getting stronger or weaker?
CWAN lead: Reversed — AVGO led by 3 AIQ points 30 sessions ago; CWAN now leads by 1. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has changed hands 4 times in that window, most recently on 2026-10-19, when CWAN moved ahead of AVGO.
What would change the AVGO vs CWAN verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: AVGO closes the Risk Resilience gap — currently 21 points behind, the largest single contributor to CWAN's edge; AVGO's Death Cross Active resolves — a bearish trend rule currently active against it; CWAN starts generating bearish momentum or trend signals; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about AVGO and CWAN?
AVGO: 0 bullish / 3 bearish. CWAN: No active signals. The most decision-relevant rule on AVGO is Death Cross Active (bearish, long horizon).
Compare AVGO and CWAN with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.